Understanding the Role of Your Stem Cells
Adult stem cells are unique, undifferentiated cells designed by your body to replenish dying cells and mend injured tissues. Sourced from your body’s fatty deposits or bone marrow through a minimally invasive procedure, these abundant stem cells can be re-infused into specific regions of the body. This promotes the generation of healthy cells and amplifies your body’s innate healing capabilities.
We exclusively utilize your individual Mesenchymal ‘adult’ stem cells, steering clear of embryonic stem cells. These exceptional cells possess the ability to transform into diverse cell types such as bone, cartilage, muscle, and fat cells, facilitating recovery and alleviating pain and inflammation.
Stem Cell Therapies We Offer
Stem cells derived from adipose (fat) tissue, known as ADSCs, are strong and readily accessible, establishing them as a dependable choice for individual cell therapy. These cells are extracted from fat obtained through a minimally invasive liposuction procedure, which is almost pain-free and conducted on an outpatient basis.
ADSCs are prolific, outnumbering those in bone marrow by up to 2,500 times. They can be harvested using just local anesthesia. Regardless of a patient’s age, these cells stay potent, having been activated only a few instances during a person’s lifetime. Their plentiful nature facilitates multiple treatments on the same day.
Mesenchymal stem cells sourced from bone marrow, akin to those derived from adipose tissue, are readily harvested using local anesthesia. They’re specifically utilized for orthopedic ailments, permitting treatments for 1-2 joints within a single day. These cells retain their potency in patients between the ages of 10-60, with overall health and age playing crucial roles in determining suitability.
We strictly refrain from using embryonic stem cells. Derived from embryos at the preimplantation stage, these cells possess the ability to transform into multiple cell types, potentially leading to tumor formations (teratomas) upon direct injection. Issues with controlled differentiation and the risk of transplant rejection continue to be concerns. Moreover, embryonic stem cells are entwined with ethical debates and inherent limitations.